Haiwen & Partners
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
The Hong Kong branch of Haiwen & Partners is geared to handle a broad range of contentious and transactional mandates, with frequent instructions in the securities, M&A, and private equity spaces. Representative work for the group ranges from the financial services, tech, and pharmaceutical sectors. On the contentious side, Edward Liu is well versed in high-stakes international arbitration and commercial litigation. Qingjian Wang is part of the transactional team and has amassed a wealth of experience advising sponsors and private equity funds, while Zuolong Wu is regularly tasked with both inbound and outbound investments across the insurance, tech, and real estate sectors.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘The team is extremely hardworking and responsive.’
‘Edward Liu has a highly diversified international practice and is especially knowledgeable and good at formulating litigation strategy in disputes across different jurisdictions which often involve Hong Kong, Mainland China, England and offshore jurisdictions such as BVI and Cayman.’
Key clients
- CITIC Securities International Company Limited
- Genor Biopharma Holdings Limited
Work highlights
Assisted CITIC Securities International Company Limited complete its sale of 40% of the shares of CLSA Premium(6877.HK), a HK listed company through domestic equity exchange, with a mandatory general offer triggered.